LANXESS Showcases Advanced Cosmetic Preservation Tech
Cologne, March 16, 2026 LANXESS announced its participation at the in-cosmetics Global 2026, scheduled from April 14 to 16...
AI drug discovery artificial intelligence Autoimmune Disease biologics Biomarkers biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology immunology Immunotherapy Medical Device Medical Devices MedTech Monoclonal Antibody Neurodegenerative Disease Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
Cologne, March 16, 2026 LANXESS announced its participation at the in-cosmetics Global 2026, scheduled from April 14 to 16...
